Vasopressin Receptor Antagonist

This page covers all Vasopressin Receptor Antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Vasopressin V2 receptor, V2 receptor, Vasopressin receptor, thymidylate synthase.

Targets

Vasopressin V2 receptor · V2 receptor · Vasopressin receptor, thymidylate synthase

Marketed (1)

• Vaprisol In 5% Dextrose In Plastic Container · Cumberland · Cardiovascular

Phase 3 pipeline (1)

• Tolvaptan Tablets · Institute of Liver and Biliary Sciences, India · Cardiovascular
  Tolvaptan is a selective, competitive antagonist of the vasopressin V2 receptor.

Phase 1 pipeline (1)

• ADH -1 and capecitabine · Adherex Technologies, Inc. · Oncology
  ADH-1 is a vasopressin receptor antagonist, and capecitabine is a thymidylate synthase inhibitor.

Patent intelligence

• vasopressin receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates